Baird’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$3.47M Buy
50,157
+5,537
+12% +$400K 0.04% 417
2014
Q4
$3.38M Buy
44,620
+228
+0.5% +$18K 0.04% 430
2014
Q3
$3.59M Buy
44,392
+401
+0.9% +$33.5K 0.05% 317
2014
Q2
$3.84M Buy
43,991
+876
+2% +$76.1K 0.05% 315
2014
Q1
$3.72M Buy
43,115
+1,185
+3% +$97.1K 0.05% 334
2013
Q4
$3.38M Buy
41,930
+2,790
+7% +$217K 0.06% 355
2013
Q3
$3.05M Buy
39,140
+2,801
+8% +$216K 0.06% 359
2013
Q2
$2.54M Buy
+36,339
New +$2.53M 0.05% 376

Other funds holding EMN

Baird's EMN Position: Q1 2015 in Review

Baird increased its Eastman Chemical (EMN) stake by 12% in Q1 2015, buying an estimated $400K and bringing the position to 50,157 shares worth $3.47M. The position accounts for 0.04% of the portfolio, ranked #417.

Baird first reported a position in EMN in Q2 2013 and has held it in 8 quarters since. The position peaked at $3.84M in Q2 2014. 559 funds tracked by Wall St. Rank hold EMN as of Q1 2015.

  • Baird held 50,157 shares of Eastman Chemical worth $3.47M as of Q1 2015.
  • Baird bought 5,537 Eastman Chemical shares in Q1 2015, an estimated $400K.
  • Eastman Chemical made up 0.04% of Baird's portfolio in Q1 2015, its #417 holding.
  • Baird first reported a position in Eastman Chemical in Q2 2013 and has held it in 8 quarters since.
  • Baird's Eastman Chemical position peaked at $3.84M in Q2 2014.
  • 559 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.